Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schiff

Showing results (131-140 of 305) with videos related to

Pageof 31
Sort By:
Neuro-Oncology|March 11, 2009
Racial differences in primary central nervous system lymphoma incidence and survival ratesJose S Pulido, Robert A Vierkant, Janet E Olson, et al.
Cell Cycle (Georgetown, Tex.)|March 2, 2010
microRNA-34a is tumor suppressive in brain tumors and glioma stem cellsFadila Guessous, Ying Zhang, Alex Kofman, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 18, 2009
An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growthFadila Guessous, Ying Zhang, Charles diPierro, et al.
Neuro-Oncology|November 1, 2014
Medical management of brain tumors and the sequelae of treatmentDavid Schiff, Eudocia Q Lee, Lakshmi Nayak, et al.
Critical Care Medicine|July 9, 2005
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factorsDeborah Cook, Mark Crowther, Maureen Meade, et al.
Journal of Neuro-Oncology|July 21, 2014
Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade gliomaJasmin Jo, Brian Williams, Mark Smolkin, et al.
Journal of Neurosurgery|July 21, 2005
The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomasMark E Shaffrey, Elana Farace, David Schiff, et al.
The Lancet. Oncology|February 3, 2007
Part II: spinal-cord neoplasms--primary tumours of the bony spine and adjacent soft tissuesCharles A Sansur, Nader Pouratian, Aaron S Dumont, et al.
Journal of Neuro-Oncology|August 21, 2025
Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progressionLalanthica V Yogendran, Abhinav Kareddy, Salma O Abbas, et al.
Neurology|November 4, 2015
Evolution of brain lesions in a patient with TREX1 cerebroretinal vasculopathyRadhika Dhamija, David Schiff, M Beatriz S Lopes, et al.
Pageof 31

Showing results (131-140 of 305) with videos related to

Sort By:
Pageof 31
Neuro-Oncology|March 11, 2009
Racial differences in primary central nervous system lymphoma incidence and survival ratesJose S Pulido, Robert A Vierkant, Janet E Olson, et al.
Cell Cycle (Georgetown, Tex.)|March 2, 2010
microRNA-34a is tumor suppressive in brain tumors and glioma stem cellsFadila Guessous, Ying Zhang, Alex Kofman, et al.
Anti-Cancer Agents in Medicinal Chemistry|December 18, 2009
An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growthFadila Guessous, Ying Zhang, Charles diPierro, et al.
Neuro-Oncology|November 1, 2014
Medical management of brain tumors and the sequelae of treatmentDavid Schiff, Eudocia Q Lee, Lakshmi Nayak, et al.
Critical Care Medicine|July 9, 2005
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factorsDeborah Cook, Mark Crowther, Maureen Meade, et al.
Journal of Neuro-Oncology|July 21, 2014
Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade gliomaJasmin Jo, Brian Williams, Mark Smolkin, et al.
Journal of Neurosurgery|July 21, 2005
The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomasMark E Shaffrey, Elana Farace, David Schiff, et al.
The Lancet. Oncology|February 3, 2007
Part II: spinal-cord neoplasms--primary tumours of the bony spine and adjacent soft tissuesCharles A Sansur, Nader Pouratian, Aaron S Dumont, et al.
Journal of Neuro-Oncology|August 21, 2025
Effects of re-challenge with temozolomide in grade 2/3 IDH mutant gliomas at first progressionLalanthica V Yogendran, Abhinav Kareddy, Salma O Abbas, et al.
Neurology|November 4, 2015
Evolution of brain lesions in a patient with TREX1 cerebroretinal vasculopathyRadhika Dhamija, David Schiff, M Beatriz S Lopes, et al.
Pageof 31